Company intelligence / Profile preview

Terranol

Copenhagen, Capital Region, Denmarkterranol.com ↗

Ownership: Private
Development stage: Other

Overview

Terranol has developed proprietary engineered yeast strains (notably cV‑110) capable of efficient co-fermentation of C6 and C5 sugars from lignocellulosic biomass. Their technology has been demonstrated at both laboratory and industrial scales, achieving high yields (>95%) in cellulosic ethanol production. The company collaborates with industry partners to reduce costs and improve scalability in second-generation bioethanol manufacturing[1].

Modalities: Yeast strainFermentation technology
Industry: Non-Drug Biotech

Partnerships

SEKAB (Sweden)RISE Research Institutes of SwedenInbicon

Beyond the preview

Go deeper on Terranol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terranol.

Explore the full profile